KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cerence (CRNC) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Cerence (CRNC) over the last 7 years, with Q4 2025 value amounting to $92.1 million.

  • Cerence's Cash & Equivalents fell 1150.11% to $92.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $92.1 million, marking a year-over-year decrease of 1150.11%. This contributed to the annual value of $84.0 million for FY2025, which is 3084.17% down from last year.
  • Latest data reveals that Cerence reported Cash & Equivalents of $92.1 million as of Q4 2025, which was down 1150.11% from $84.0 million recorded in Q3 2025.
  • In the past 5 years, Cerence's Cash & Equivalents ranged from a high of $128.4 million in Q3 2021 and a low of $17.7 million during Q2 2022
  • Moreover, its 5-year median value for Cash & Equivalents was $100.2 million (2023), whereas its average is $99.5 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 8533.85% in 2022, then soared by 38597.39% in 2023.
  • Over the past 5 years, Cerence's Cash & Equivalents (Quarter) stood at $117.2 million in 2021, then decreased by 22.67% to $90.7 million in 2022, then grew by 8.91% to $98.7 million in 2023, then grew by 5.44% to $104.1 million in 2024, then fell by 11.5% to $92.1 million in 2025.
  • Its Cash & Equivalents was $92.1 million in Q4 2025, compared to $84.0 million in Q3 2025 and $73.7 million in Q2 2025.